U.S. market Closed. Opens in 11 hours 46 minutes

BIOR | Biora Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue4.00K305.00K1.25M74.31M143.99M127.97M
Cost of Revenue555.00K907.00K1.44M93.43M100.49M92.08M
Gross Profit-551.00K-602.00K-190.00K-19.12M43.49M35.90M
Operating Expenses66.59M62.09M119.08M176.07M183.61M150.14M
Selling, General & Admin36.75M38.04M73.30M128.32M120.21M101.42M
Research & Development29.84M24.05M45.78M47.74M63.40M48.71M
Other Operating Expenses-65.47M2.62M5.99M-25.08MN/AN/A
Operating Income-67.14M-61.78M-117.84M-195.19M-140.12M-114.24M
Other Expenses / Income-57.28M12.53M-60.80M-34.87M-8.62M-2.33M
Before Tax Income-124.42M-49.25M-178.64M-230.06M-148.74M-123.86M
Income Tax Expenses-90.00K-420.00K-119.00K-37.53M-706.00K5.25M
Net Income-124.11M-48.83M-178.52M-192.53M-148.04M-129.11M
Interest Expenses9.81M10.99M-12.64M34.87M9.20M9.09M
Basic Shares Outstanding15.77M7.64M3.85M2.23M1.85M1.08M
Diluted Shares Outstanding15.77M7.64M3.85M2.23M1.85M1.08M
EBITDA-66.59M-59.16M-63.68M-195.19M-133.19M-108.69M
EBITDA Margin-1,664,699.98%-19,398.03%-5,106.66%-262.66%-92.51%-84.93%
EBIT-114.39M-38.26M-191.28M-195.19M-139.54M-114.77M
EBIT Margin-2,859,750.00%-12,544.26%-15,338.89%-262.66%-96.92%-89.68%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙